Lactational exposure of phthalate impairs insulin signaling in the cardiac muscle of F1 female albino rats

Cardiovascular Toxicology

Volumn 14, Issue 1, 2014, Pages 10-20

  Mangala Priya, Viswanathan ^a   Mayilvanan, Chinnaiyan ^a   Akilavalli, Narasimhan ^a   Rajesh, Parsanathan ^a   Balasubramanian, Karundevi ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Cardiac muscle; DEHP; Insulin resistance; Lactational exposure; Type 2 diabetes

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PROTEIN KINASE B; SERINE; TYROSINE;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOSOL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; HEART MUSCLE; INSULIN RELEASE; INSULIN RESISTANCE; LACTATION; LONG TERM EXPOSURE; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PUERPERIUM; RAT; SIGNAL TRANSDUCTION;

ANIMALIA; RATTUS;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIETHYLHEXYL PHTHALATE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCRINE DISRUPTORS; FEMALE; GLUCOSE TRANSPORTER TYPE 4; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; LACTATION; MYOCARDIUM; OXIDATION-REDUCTION; PHOSPHORYLATION; PLASTICIZERS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 84895787001     PISSN: 15307905     EISSN: 15590259     Source Type: Journal    
DOI: 10.1007/s12012-013-9233-z     Document Type: Article

References (63)

1. Eckardt, K.; Taube, A.; Eckel, J. (2011). Obesity-associated insulin resistance in skeletal muscle: Role of lipid accumulation and physical inactivity. Reviews in Endocrine and Metabolic Disorders, 12, 163-172.
2. Hectors, T. L.; Vanparys, C.; van der Ven, K.; Martens, G. A.; Jorens, P. G.; Van Gaal, L. F.; et al. (2011). Environmental pollutants and type 2 diabetes: A review of mechanisms that can disrupt beta cell function. Diabetologia, 54, 1273-1290.
3. Kobayashi, K.; Miyagawa, M.; Wang, R. S.; Suda, M.; Sekiguchi, S.; Honma, T. (2006). Effects of in utero and lactational exposure to di(2-ethylhexyl) phthalate on somatic and physical development in rat offspring. Industrial Health, 44, 652-660.
4. Fay, M.; Donohue, J. M.; De Rosa, C. (1999). ATSDR evaluation of health effects of chemicals. VI. Di(2-ethylhexyl)phthalate. Agency for toxic substances and disease registry. Toxicology and Industrial Health, 15, 651-746.
5. FDA. (2002). Safety assessment of Di(2-ethylhexyl)phthalate (DEHP) released from PVC medical devices, (Administration, F.a.D.; ed).
6. ATSDR. (2002). Toxicological Profile for Di(2-ethylhexyl)phthalate (DEHP). Atlanta, GA: Agency for toxic substances and disease registry. Available: http://www.atsdr.cdc.gov/toxprofiles/tp9.html (Accessed 11 August 2003).
7. NTP-CERHR. (2006). NTP-CERHR monograph on the potential human reproductive and developmental effects of Di(2-Ethylhexyl) Phthalate (DEHP), U.S. Department of Health and Human Services.
8. Desvergne, B.; Feige, J. N.; Casals-Casas, C. (2009). PPAR-mediated activity of phthalates: A link to the obesity epidemic? Molecular and Cellular Endocrinology, 304, 43-48.
9. Martinelli, M. I.; Mocchiutti, N. O.; Bernal, C. A. (2006). Dietary di(2-ethylhexyl)phthalate-impaired glucose metabolism in experimental animals. Human and Experimental Toxicology, 25, 531-538.
10. Stahlhut, R. W.; van Wijngaarden, E.; Dye, T. D.; Cook, S.; Swan, S. H. (2007). Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males. Environmental Health Perspectives, 115, 876-882.
11. Hatch, E. E.; Nelson, J. W.; Qureshi, M. M.; Weinberg, J.; Moore, L. L.; Singer, M.; et al. (2008). Association of urinary phthalate metabolite concentrations with body mass index and waist circumference: A cross-sectional study of NHANES data, 1999-2002. Environmental Health: A Global Access Science Source, 7, 27.
12. Rengarajan, S.; Parthasarathy, C.; Anitha, M.; Balasubramanian, K. (2007). Diethylhexyl phthalate impairs insulin binding and glucose oxidation in Chang liver cells. Toxicology In Vitro: An International Journal Published in Association With BIBRA, 21, 99-102.
13. Srinivasan, C.; Khan, A. I.; Balaji, V.; Selvaraj, J.; Balasubramanian, K. (2011). Diethyl hexyl phthalate-induced changes in insulin signaling molecules and the protective role of antioxidant vitamins in gastrocnemius muscle of adult male rat. Toxicology and Applied Pharmacology, 257, 155-164.
14. Rajesh, P.; Sathish, S.; Srinivasan, C.; Selvaraj, J.; Balasubramanian, K. (2013). Phthalate is associated with insulin resistance in adipose tissue of male rat: Role of antioxidant vitamins. Journal of Cellular Biochemistry, 114, 558-569.
15. Calafat, A. M.; Slakman, A. R.; Silva, M. J.; Herbert, A. R.; Needham, L. L. (2004). Automated solid phase extraction and quantitative analysis of human milk for 13 phthalate metabolites. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences, 805, 49-56.
16. Latini, G.; De Felice, C.; Presta, G.; Del Vecchio, A.; Paris, I.; Ruggieri, F.; et al. (2003). In utero exposure to di-(2-ethylhexyl)phthalate and duration of human pregnancy. Environmental Health Perspectives, 111, 1783-1785.
17. Latini, G. (2000). Potential hazards of exposure to di-(2-ethylhexyl)- phthalate in babies. A Review. Biology of the Neonate, 78, 269-276.
18. WHO. (2002). Global assessment of the state-of-the-science of endocrine disruptors.
19. Lin, Y.; Wei, J.; Li, Y.; Chen, J.; Zhou, Z.; Song, L.; et al. (2011). Developmental exposure to di(2-ethylhexyl) phthalate impairs endocrine pancreas and leads to long-term adverse effects on glucose homeostasis in the rat. American Journal of Physiology. Endocrinology and Metabolism, 301, E527-E538.
20. Gillum, N.; Karabekian, Z.; Swift, L. M.; Brown, R. P.; Kay, M. W.; Sarvazyan, N. (2009). Clinically relevant concentrations of di (2-ethylhexyl) phthalate (DEHP) uncouple cardiac syncytium. Toxicology and Applied Pharmacology, 236, 25-38.
21. Posnack, N. G.; Lee, N. H.; Brown, R.; Sarvazyan, N. (2011). Gene expression profiling of DEHP-treated cardiomyocytes reveals potential causes of phthalate arrhythmogenicity. Toxicology, 279, 54-64.
22. Johnson, A. D.; Turner, P. C. (1971). Epididymal carbohydrate metabolism. I. Glucose-1-14-C and glucose-6-14-C metabolism by mouse, rat and rabbit tissues. Comparative Biochemistry and Physiology A, Comparative Physiology, 39, 599-604.
23. Kraft, L. A.; Johnson, A. D. (1972). Epididymal carbohydrate metabolism. II. Substrates and pathway utilization of caput and cauda epididymal tissue from the rabbit, rat and mouse. Comparative Biochemistry and Physiology B, Comparative Biochemistry, 42, 451-461.
24. Ishizuka, T.; Kajita, K.; Miura, A.; Ishizawa, M.; Kanoh, Y.; Itaya, S.; et al. (1999). DHEA improves glucose uptake via activations of protein kinase C and phosphatidylinositol 3-kinase. The American Journal of Physiology, 276, E196-E204.
25. Dombrowski, L.; Roy, D.; Marcotte, B.; Marette, A. (1996). A new procedure for the isolation of plasma membranes, T tubules, and internal membranes from skeletal muscle. The American journal of physiology, 270, E667-E676.
26. Kristiansen, S.; Nielsen, J. N.; Bourgoin, S.; Klip, A.; Franco, M.; Richter, E. A. (2001). GLUT-4 translocation in skeletal muscle studied with a cell-free assay: Involvement of phospholipase D. American Journal of Physiology. Endocrinology and Metabolism, 281, E608-E618.
27. Lowry, O. H.; Rosebrough, N. J.; Farr, A. L.; Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. The Journal of Biological Chemistry, 193, 265-275.
28. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
29. Latini, G.; De Felice, C.; Verrotti, A. (2004). Plasticizers, infant nutrition and reproductive health. Reproductive Toxicology, 19, 27-33.
30. Hauser, R.; Calafat, A. M. (2005). Phthalates and human health. Occupational and Environmental Medicine, 62, 806-818.
31. Faouzi, M. A.; Dine, T.; Gressier, B.; Kambia, K.; Luyckx, M.; Pagniez, D.; et al. (1999). Exposure of hemodialysis patients to di-2-ethylhexyl phthalate. International Journal of Pharmaceutics, 180, 113-121.
32. Shneider, B.; Schena, J.; Truog, R.; Jacobson, M.; Kevy, S. (1989). Exposure to di(2-ethylhexyl)phthalate in infants receiving extracorporeal membrane oxygenation. The New England Journal of Medicine, 320, 1563.
33. Davis, B. J.; Maronpot, R. R.; Heindel, J. J. (1994). Di-(2-ethylhexyl) phthalate suppresses estradiol and ovulation in cycling rats. Toxicology and Applied Pharmacology, 128, 216-223.
34. Treinen, K. A.; Dodson, W. C.; Heindel, J. J. (1990). Inhibition of FSH-stimulated cAMP accumulation and progesterone production by mono(2-ethylhexyl) phthalate in rat granulosa cell cultures. Toxicology and Applied Pharmacology, 106, 334-340.
35. Young, L. H. (2010). Diet-induced obesity obstructs insulin signaling in the heart. American Journal of Physiology. Heart and Circulatory Physiology, 298, H306-H307.
36. Belke, D. D.; Betuing, S.; Tuttle, M. J.; Graveleau, C.; Young, M. E.; Pham, M.; et al. (2002). Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. The Journal of Clinical Investigation, 109, 629-639.
37. Muniyappa, R.; Montagnani, M.; Koh, K. K.; Quon, M. J. (2007). Cardiovascular actions of insulin. Endocrine Reviews, 28, 463-491.
38. Gayathri, N. S.; Dhanya, C. R.; Indu, A. R.; Kurup, P. A. (2004). Changes in some hormones by low doses of di (2-ethyl hexyl) phthalate (DEHP), a commonly used plasticizer in PVC blood storage bags & medical tubing. The Indian Journal of Medical Research, 119, 139-144.
39. Livingstone, C.; Collison, M. (2002). Sex steroids and insulin resistance. Clinical Science, 102, 151-166.
40. Svensson, K.; Hernandez-Ramirez, R. U.; Burguete-Garcia, A.; Cebrian, M. E.; Calafat, A. M.; Needham, L. L.; et al. (2011). Phthalate exposure associated with self-reported diabetes among Mexican women. Environmental Research, 111, 792-796.
41. Ferre, P. (2004). The biology of peroxisome proliferator-activated receptors: Relationship with lipid metabolism and insulin sensitivity. Diabetes, 53(Suppl 1), S43-S50.
42. Brun, R. P.; Kim, J. B.; Hu, E.; Spiegelman, B. M. (1997). Peroxisome proliferator-activated receptor gamma and the control of adipogenesis. Current Opinion in Lipidology, 8, 212-218.
43. Tontonoz, P.; Nagy, L.; Alvarez, J. G.; Thomazy, V. A.; Evans, R. M. (1998). PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell, 93, 241-252.
44. Batista, T. M.; Alonso-Magdalena, P.; Vieira, E.; Amaral, M. E.; Cederroth, C. R.; Nef, S.; et al. (2012). Short-term treatment with bisphenol-A leads to metabolic abnormalities in adult male mice. PLoS One, 7, e33814.
45. Desrois, M.; Sidell, R. J.; Gauguier, D.; King, L. M.; Radda, G. K.; Clarke, K. (2004). Initial steps of insulin signaling and glucose transport are defective in the type 2 diabetic rat heart. Cardiovascular Research, 61, 288-296.
46. Pessin, J. E.; Saltiel, A. R. (2000). Signaling pathways in insulin action: Molecular targets of insulin resistance. The Journal of Clinical Investigation, 106, 165-169.
47. Santhosh, A.; Nair, K. G.; Arun, P.; Deepadevi, K. V.; Manojkumar, V.; Lakshmi, L. R.; et al. (1998). Effect of DEHP [di-(2-ethyl hexyl) phthalate] on lipid peroxidation in liver in rats and in primary cultures of rat hepatocytes. The Indian Journal of Medical Research, 108, 17-23.
48. Garcia-Arencibia, M.; Davila, N.; Campion, J.; Carmen Carranza, M.; Calle, C. (2005). Identification of two functional estrogen response elements complexed with AP-1-like sites in the human insulin receptor gene promoter. The Journal of Steroid Biochemistry and Molecular Biology, 94, 1-14.
49. Xie, P.; Liu, M. L.; Gu, Y. P.; Lu, J.; Xu, X.; Zeng, W. M.; et al. (2003). Oestrogen improves glucose metabolism and insulin signal transduction in HepG2 cells. Clinical and Experimental Pharmacology and Physiology, 30, 643-648.
50. Khan, A. H.; Pessin, J. E. (2002). Insulin regulation of glucose uptake: a complex interplay of intracellular signalling pathways. Diabetologia, 45, 1475-1483.
51. Kaneto, H.; Katakami, N.; Matsuhisa, M.; Matsuoka, T. A. (2010). Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediators of Inflammation, 2010, 453892.
52. Potashnik, R.; Bloch-Damti, A.; Bashan, N.; Rudich, A. (2003). IRS1 degradation and increased serine phosphorylation cannot predict the degree of metabolic insulin resistance induced by oxidative stress. Diabetologia, 46, 639-648.
53. Pirola, L.; Johnston, A. M.; Van Obberghen, E. (2004). Modulation of insulin action. Diabetologia, 47, 170-184.
54. Rusyn, I.; Kadiiska, M. B.; Dikalova, A.; Kono, H.; Yin, M.; Tsuchiya, K.; et al. (2001). Phthalates rapidly increase production of reactive oxygen species in vivo: Role of Kupffer cells. Molecular Pharmacology, 59, 744-750.
55. Peraldi, P.; Xu, M.; Spiegelman, B. M. (1997). Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling. The Journal of Clinical Investigation, 100, 1863-1869.
56. Teruel, T.; Hernandez, R.; Lorenzo, M. (2001). Ceramide mediates insulin resistance by tumor necrosis factor-alpha in brown adipocytes by maintaining Akt in an inactive dephosphorylated state. Diabetes, 50, 2563-2571.
57. Slot, J. W.; Geuze, H. J.; Gigengack, S.; James, D. E.; Lienhard, G. E. (1991). Translocation of the glucose transporter GLUT4 in cardiac myocytes of the rat. Proceedings of the National Academy of Sciences of the United States of America, 88, 7815-7819.
58. Uphues, I.; Kolter, T.; Goud, B.; Eckel, J. (1995). Failure of insulin-regulated recruitment of the glucose transporter GLUT4 in cardiac muscle of obese Zucker rats is associated with alterations of small-molecular-mass GTP-binding proteins. The Biochemical Journal, 311(Pt 1), 161-166.
59. Russell, R. R, 3rd, Bergeron, R.; Shulman, G. I.; Young, L. H. (1999). Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. The American Journal of Physiology, 277, H643-H649.
60. Finck, B. N.; Bernal-Mizrachi, C.; Han, D. H.; Coleman, T.; Sambandam, N.; LaRiviere, L. L.; et al. (2005). A potential link between muscle peroxisome proliferator- activated receptor-alpha signaling and obesity-related diabetes. Cell Metabolism, 1, 133-144.
61. Lizunov, V. A.; Matsumoto, H.; Zimmerberg, J.; Cushman, S. W.; Frolov, V. A. (2005). Insulin stimulates the halting, tethering, and fusion of mobile GLUT4 vesicles in rat adipose cells. The Journal of Cell Biology, 169, 481-489.
62. Lapinskas, P. J.; Brown, S.; Leesnitzer, L. M.; Blanchard, S.; Swanson, C.; Cattley, R. C.; et al. (2005). Role of PPARalpha in mediating the effects of phthalates and metabolites in the liver. Toxicology, 207, 149-163.
63. Park, S. Y.; Cho, Y. R.; Kim, H. J.; Higashimori, T.; Danton, C.; Lee, M. K.; et al. (2005). Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice. Diabetes, 54, 3530-3540.